Simplex Trading, LLC Apellis Pharmaceuticals, Inc. Transaction History

Simplex Trading, LLC

  • $2.98 Billion
  • Q2 2024

A detailed history of Simplex Trading, LLC transactions in Apellis Pharmaceuticals, Inc. stock. As of the latest transaction made, Simplex Trading, LLC holds 70,072 shares of APLS stock, worth $2.09 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
70,072
Holding current value
$2.09 Million
% of portfolio
0.09%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 25, 2024
BUY
$38.07 - $59.71 $2.67 Million - $4.18 Million
70,072 New
70,072 $2.69 Million
Q4 2023

Feb 02, 2024
SELL
$37.14 - $64.82 $1.19 Million - $2.07 Million
-31,911 Reduced 41.52%
44,954 $2.69 Million
Q3 2023

Nov 01, 2023
BUY
$23.65 - $89.22 $20,197 - $76,193
854 Added 1.12%
76,865 $2.92 Million
Q2 2023

Aug 04, 2023
BUY
$76.68 - $93.31 $5.57 Million - $6.77 Million
72,588 Added 2120.6%
76,011 $6.92 Million
Q1 2023

Apr 27, 2023
BUY
$46.59 - $66.96 $159,477 - $229,204
3,423 New
3,423 $225,000
Q3 2022

Nov 04, 2022
BUY
$44.76 - $69.66 $871,163 - $1.36 Million
19,463 Added 191.49%
29,627 $2.02 Million
Q2 2022

Aug 03, 2022
BUY
$35.07 - $59.21 $252,398 - $426,134
7,197 Added 242.57%
10,164 $459,000
Q1 2022

May 02, 2022
BUY
$35.46 - $54.12 $105,209 - $160,574
2,967 New
2,967 $150,000
Q1 2021

Apr 26, 2021
SELL
$40.8 - $57.39 $59,404 - $83,559
-1,456 Closed
0 $0
Q4 2020

Feb 02, 2021
SELL
$30.79 - $57.2 $86,458 - $160,617
-2,808 Reduced 65.85%
1,456 $0
Q3 2020

Oct 14, 2020
SELL
$25.89 - $33.65 $6,757 - $8,782
-261 Reduced 5.77%
4,264 $0
Q2 2020

Jul 13, 2020
SELL
$24.8 - $38.49 $35,439 - $55,002
-1,429 Reduced 24.0%
4,525 $147,000
Q1 2020

Apr 29, 2020
BUY
$17.91 - $44.33 $106,636 - $263,940
5,954 New
5,954 $159,000
Q4 2019

Feb 05, 2020
SELL
$22.1 - $30.8 $55,006 - $76,661
-2,489 Closed
0 $0
Q3 2019

Oct 15, 2019
BUY
$24.09 - $32.18 $58,153 - $77,682
2,414 Added 3218.67%
2,489 $59,000
Q2 2019

Jul 26, 2019
BUY
$18.0 - $25.34 $1,350 - $1,900
75 New
75 $1,000

Others Institutions Holding APLS

# of Institutions
299
Shares Held
113M
Call Options Held
5.21M
Put Options Held
691K
View Full List

About Apellis Pharmaceuticals, Inc.

APLS Quotes by TradingView
  • Ticker APLS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 109,865,000
  • Market Cap $3.28B
  • Description
  • Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...
More about APLS
Track This Portfolio

Track Simplex Trading, LLC Portfolio

Follow Simplex Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email